{"schema_version":"secwatch.filing_event.v1","accession":"0001932393-24-000017","form_type":"8-K/A","ticker":"GEHC","cik":"0001932393","company_name":"GE HealthCare Technologies Inc.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.331573+00:00","generated_at":"2026-06-06T08:36:09.778046+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"GE HealthCare Q4 rev $5.2B (+5% organic), adj EPS $1.18; FY2024 adj EPS guide $4.20-$4.35","bullets":["Q4 revenue $5.2B, up 5% organic YoY; net income $403M ($0.88 EPS) vs $554M ($1.21) prior year.","Adjusted EBIT margin 16.1% in Q4, flat vs standalone prior year; full year adj EBIT margin 15.1% vs 14.5% standalone prior year.","Full year revenue $19.6B (+7% reported, +8% organic); orders book-to-bill 1.03x.","2024 guidance: organic rev growth ~4%, adj EBIT margin 15.6%-15.9%, adj EPS $4.20-$4.35, FCF ~$1.8B.","Repaid $850M debt in Q4, $150M in Jan 2024; announced agreement to acquire MIM Software (no value disclosed)."],"urls":{"canonical":"https://secwatch.observer/filing/0001932393-24-000017","json":"https://secwatch.observer/filing/0001932393-24-000017.json","markdown":"https://secwatch.observer/filing/0001932393-24-000017.md","text":"https://secwatch.observer/filing/0001932393-24-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/0001932393-24-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/gehc-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:36:09.778046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b4a85b2890ce568a1d69de25ec7e2ec311008d3","claim":"GE HealthCare Technologies Inc. reported fourth quarter ended December 31, 2023 results: revenue $5.2 billion, net income $403 million, EPS $0.88.","evidence_excerpt":"growth. We’re confident heading into 2024 amid the backdrop of an improved capital equipment landscape.” Fourth Quarter 2023 Total Company Financial Performance • Revenues of $5.2 billion increased 5% on both a reported and Organic* basis year-over-year, driven by price and volume. • Total company book-to-bill was strong at 1.05 times, defined as Total orders","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/0001932393-24-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$5.2 billion"},{"label":"Net income","value":"$403 million"},{"label":"EPS","value":"$0.88"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"eb082b341336a16a93f466590da18354fc7deee0","claim":"GE HealthCare Technologies Inc. reported the fiscal year ended December 31, 2023 results: revenue $19.6 billion, net income $1.6 billion, EPS $3.04. Guidance reaffirmed.","evidence_excerpt":"million versus $109 million for the prior year. • Segment EBIT margin was 24.4% versus 23.0% for the prior year. Full Year 2023 Total Company Financial Performance • Revenues of $19.6 billion increased 7% year-over-year and 8% on an Organic* basis with growth across all segments and regions. • Total company book-to-bill was 1.03 times, as orders dollars outpaced","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1932393/000193239324000017/0001932393-24-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$19.6 billion"},{"label":"Net income","value":"$1.6 billion"},{"label":"EPS","value":"$3.04"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}